Peptidoglycan synthesis is an important target for antibiotics and relies on intermediates derived from central metabolism. As a result, alterations of metabolism may affect antibiotic sensitivity. An aspB mutant is auxotrophic for aspartate (Asp) and asparagine (Asn) and lyses when grown in Difco sporulation medium (DSM), but not in LB medium. Genetic and physiological studies, supported by amino acid analysis, reveal that cell lysis in DSM results from Asp limitation due to a relatively low Asp and high glutamate (Glu) concentrations, with Glu functioning as a competitive inhibitor of Asp uptake by the major Glu/Asp transporter GltT. Lysis can be specifically suppressed by supplementation with 2,6-diaminopimelate (DAP), which is imported by two different cystine uptake systems. These studies suggest that aspartate limitation depletes the peptidoglycan precursor meso-2,6-diaminopimelate (mDAP), inhibits peptidoglycan synthesis, upregulates the cell envelope stress response mediated by σ M and eventually leads to cell lysis. Aspartate limitation sensitizes cells to antibiotics targeting late steps of PG synthesis, but not steps prior to the addition of mDAP into the pentapeptide sidechain. This work highlights the ability of perturbations of central metabolism to sensitize cells to peptidoglycan synthesis inhibitors.
Introduction
Bacillus subtilis is a metabolically versatile soil bacterium and can synthesize all 20 amino acids. Amino acids are essential for synthesis of proteins and other macromolecules, and many can also be catabolized to yield intermediates of the tricarboxylic acid (TCA) cycle. Amino acid metabolism is governed by master regulators, such as CcpA, TnrA and CodY, working in concert with pathway-specific regulation by transcriptional, translational and post-translational mechanisms in a complex, interlinked network (Sonenshein, 2007; Brantl and Licht, 2010; Geiger and Wolz, 2014) .
Glutamate (Glu) serves as a central link between nitrogen and carbon metabolism and, together with aspartate, functions as a key branch point amino acid linking amino acid biosynthesis with central carbon metabolism (Fig. 1 ). Glutamate is synthesized by glutamate synthase (also known as glutamine oxoglutarate aminotransferase, GOGAT), encoded by gltAB in B. subtilis, which converts one molecule each of Gln and α-ketoglutarate into two molecules of Glu. Glutamate can be imported into the cell by GltT (Zaprasis et al., 2015) , GltP (Tolner et al., 1995) and YveA (Lorca et al., 2003) .
Glutamate homeostasis is tightly regulated in B. subtilis . Expression of gltAB is under control of GltC, which senses the ratio between Glu (the product) and α-ketoglutarate (the substrate) (Picossi et al., 2007) . When growing in medium containing glucose and ammonium, cells are rich in TCA cycle intermediates and GltC is bound to α-ketoglutarate and activates expression of gltAB (Commichau et al., 2007; Picossi et al., 2007) . When intracellular Glu is high, Glu binds to GltC and represses gltAB (Picossi et al., 2007) . In the presence of Arg or other amino acids that can be metabolized into Glu, the glutamate dehydrogenase RocG is induced and degrades Glu into α-ketoglutarate and ammonium (Belitsky and Sonenshein, 1998) . GltC can also physically interact with RocG and it was suggested that this interaction affects GltC activity (Commichau et al., 2007; Picossi et al., 2007) . B. subtilis 168 contains two genes encoding glutamate dehydrogenases, a functional rocG gene and cryptic gudB gene (Belitsky and Sonenshein, 1998) . When a rocG null mutant grows on complex sporulation medium, there is strong selection for mutations that regenerate functional gudB , highlighting the importance of maintaining Glu homeostasis in the cell. In addition to serving as a major nitrogen donor and anion in the cell and a precursor for protein synthesis, Glu is also important for cell wall synthesis. D-glutamate, synthesized by glutamate racemase from L-glutamate, is incorporated into the pentapeptide side-chain of the peptidoglycan (PG) precursor lipid II. Mutations that affect Glu homeostasis have been found to affect resistance to antibiotics targeting early (fosfomycin) and late (beta-lactams) stages of PG synthesis (Lee et al., 2012) .
In contrast with Glu, synthesis of Asp is not known to be tightly regulated. The main pathway of Asp synthesis in B. subtilis is through aspartate transaminase AspB, which transfers an amino group from Glu to oxaloacetate to form Asp ( Fig. 1) (Ochi et al., 1981) . AspB is constitutively and highly expressed, and is one of the most abundant proteins in vegetative cells (Eymann et al., 2004) . Asp is imported by GltT, GltP and YveA (Zaprasis et al., 2015) , which are also involved in Glu uptake. In B. subtilis, Asp can also be generated from Asn by L-asparaginases AnsA and AnsZ (Sun and Setlow, 1991) . However, their regulation indicates that these asparaginases function in degradation of Asn (and then Asp) ultimately yielding fumarate (Daniel and Errington, 1993; Fisher and Wray, 2002) .
Aspartate is the starting point for synthesis of the Asp family amino acids, which include Asn, Lys, Thr, Met and Ile. The pathway that generates Lys includes both mesodiaminopimelate (mDAP), which is used in PG synthesis in many bacteria, and a branch point to dipicolinate, important for heat resistance of endospores (Chen et al., 1993; Daniel and Errington, 1993) (Fig. 1) . The regulation of Asp usage mostly results from feedback inhibition (Dumas et al., 2012) . For example, three aspartokinases convert L-aspartate into L-aspartyl-4-phosphate, the first committed step for generating Asp family amino acids (except Asn). Aspartokinase I (DapG) is feedback inhibited by mDAP but not L,L-diaminopimelate (DAP) (Rosner and Paulus, 1971; Chen et al., 1993) , aspartokinase II (LysC) by Lys (Zhang et al., 1990) , and aspartokinase III (ThrD) by the simultaneous presence of Thr and Lys (Graves and Switzer, 1990; Kobashi et al., 2001,) . The branch point enzyme homoserine dehydrogenase (Hom) initiates the synthesis of Met, Thr and Ile, and can be feedback inhibited by these products (Gutierrez-Preciado et al., 2009) .
In bacteria, the amino acid composition of the stem pentapeptide of PG is typically L-Ala 1 -D-Glu 2 -mDAP 3 -DAla 4 -D-Ala 5 , with the third amino acid being L-lysine in some bacteria (Zhao et al., 2017) . Whether mDAP 3 or L-Lys 3 is used mainly depends on the substrate specificity of the corresponding ligase (MurE), as well as the cytoplasmic concentration of L-lysine versus mDAP (Ruane et al., 2013) . Because of its essential role in PG synthesis, the stem pentapeptide serves as an important target for antibiotics including D-cycloserine, vancomycin and teicoplanin. D-cycloserine is a mimic of D-Ala, and inhibits D-Ala-D-Ala synthesis by inhibiting both alanine racemase (Alr) and D-Ala-D-Ala ligase (Ddl) (Strominger et al., 1960) . Vancomycin inhibits PG synthesis by binding to the D-Ala 4 -D-Ala 5 termini of stem peptides thereby preventing transpeptidation (Arthur et al., 1996) .
In this work, we characterized the growth properties of a B. subtilis aspB mutant in a variety of nutrient conditions, which revealed that Asp limitation under otherwise nutrient rich conditions leads to depletion of mDAP and cell lysis. Aspartate limitation is exacerbated by high concentrations of Glu, which competitively inhibits Asp import. Depletion of mDAP can be rescued by addition of its precursor DAP, which is imported through two cystine uptake systems, TcyABC and TcyP. Under these conditions, Asp deficiency sensitizes cells to antibiotics targeting late steps of PG synthesis, thereby highlighting the intimate connection between central metabolism, PG synthesis and antibiotic susceptibility.
Results

An aspartate transaminase mutant lyses on Difco sporulation medium (DSM)
Moenomycin (MOE) is an antibiotic that inhibits the transglycosylase activity of class A PBPs for peptidoglycan synthesis (Fig. 1) . During a transposon library selection for MOE resistant (MOE R ) mutants, we identified multiple independent insertions in ypmB (Hachmann, 2010) , encoding a membrane protein of unknown function. A ypmB mutant has recently been shown to suppress the tetracycline sensitivity of an ezrA mutation (and the name tseB was therefore proposed) and has a reduced cell length (Gamba et al., 2015) . However, the physiological function of YpmB remains unknown.
Interestingly, when grown on Difco sporulation medium (DSM) plates (a medium that induces sporulation), a ypm-B::mls mutant exhibited pronounced cell lysis (Guariglia, 2013) . Since ypmB is the second gene in a three-gene operon (ypmA-ypmB(tseB)-aspB) ( Fig. 2A) (Fig. 2B) . Indeed, ectopic expression of aspB increased MOE R rather than restoring sensitivity (Fig. 2B ). In contrast, the DSM lysis phenotype was suppressed by aspB, but not ypmB ( Fig. 2C and D (Yeats et al., 2004 , Gamba et al., 2015 . Here, we focus on the role of AspB in preventing cell lysis on DSM.
Since the DSM lysis phenotype of the ypmB::mls mutant strain appeared to result from polarity, we next tested the growth properties of an aspB null mutant. When grown on a DSM plate at 37˚C overnight, an aspB null mutant lysed and this phenotype was complemented by ectopic expression of aspB (Fig. 2C ). When grown in liquid DSM, an aspB null mutant grew to OD 600 ~0.25 and lysed back to OD 600 ~0.1 (Fig. 2D) , suggestive of nutrient limitation. In comparison, an aspB mutant grew almost as well as the B. subtilis 168 parent strain (WT) in LB medium (Fig. 2B) , which is richer in amino acids (Table 1, SI Datasheet).
The aspB gene encodes aspartate transaminase (interconverting L-glutamate and oxaloacetate with L-aspartate and α-ketoglutarate; Fig. 1 ), and an aspB null mutant is an Asp/Asn auxotroph ( Fig. S1A and B) , as previously reported (Ochi et al., 1981) . Supplementation of DSM with 10 mM Asp (final concentration) greatly increased cell yield and completely suppressed lysis (Fig. 3A) , suggesting that limitation for Asp may trigger lysis. Asn can be converted to Asp by two asparaginases, AnsA and AnsZ (Fisher and Wray, 2002) . Consistently, addition of 10 mM Asn (final concentration) also suppressed the lysis phenotype in DSM (Fig. 3A) .
Lysis of aspB results from depletion of Asp and competition with Glu for GltT
Deletion of aspB blocks both the synthesis of Asp and the consumption of Glu, and under conditions of limiting Asp supply from the medium could lead to either depletion of Asp or accumulation of Glu in the cells. Because of the importance of Glu homeostasis in Bacillus subtilis, we first investigated whether the lysis of aspB on DSM is due to intracellular accumulation of Glu. Indeed, addition of 10 mM Glu (final concentration) to DSM medium reduced the peak OD 600 of the aspB null mutant from ~0.25 to ~0.15 (Fig. 3A) . Furthermore, in minimal medium (MM) high Glu antagonized the ability of Asp to support aspB growth (Fig. S1C) . In B. subtilis, Gln is a preferred nitrogen source and can be readily converted into Glu (Detsch and Stulke, 2003) . However, a high concentration of Gln (5 or 10 mM) did not have a similar inhibitory effect (Fig. 3A , and S1C), although under this condition intracellular Glu levels should also be elevated. This led us to hypothesize that rather than being toxic itself, due to intracellular accumulation, Glu was acting as an antagonist of Asp import.
Glu and Asp can be imported by three Glu/Asp transporters, GltP, YveA and GltT (Tolner et al., 1995; Lorca et al., 2003) , with GltT being the major importer for both amino acids (Zaprasis et al., 2015) . To test whether growth inhibition of the aspB mutant by Glu might be caused by competitive inhibition of Asp import, we mutated each of the three Asp/Glu importers in an aspB null mutant to see if the deletion of an importer would mimic the addition of Glu. Although deletion of gltP or yveA in the aspB mutant did not cause a noticeable growth defect, inactivation of gltT greatly reduced the growth yield (peak OD 600 ) of the aspB mutant (Fig. 3B ), similar to that seen for the aspB single mutant growing in DSM supplemented with Glu (Fig. 3A) . Thus, direct inactivation of Asp uptake by A. Genetic arrangement of the ypmAypmBaspB operon. B. Representative growth curves of strains in liquid LB with or without 1 μg ml -1 moenomycin. C. Colony morphology of strains on DSM plates after 20 h of incubation at 37˚C. D. Representative growth curves of strains in liquid DSM. 1 mM final concentration of IPTG are used to induce P spac(hy) promoter. All growth curves were measured at least 3 times with similar results. A representative measurement is shown. Strains used were ypmB::mls (HB12259), ∆aspB (HB17401), ypmB::mls P spac(hy) -ypmB (HB22913), ypmB::mls P spac(hy) -aspB (HB17062), and aspB::kan P spac(hy) -aspB (HB17060). Note that indistinguishable phenotypes were observed for the ∆aspB and aspB::kan strains. [Colour figure can be viewed at wileyonlinelibrary.com] deleting gltT mimics the presence of high Glu, which may competitively inhibit uptake of Asp by GltT.
To further demonstrate that lysis is affected by relative concentrations of Asp and Glu in the medium, we altered cells to increase consumption of Glu. Glutamate is degraded by glutamate dehydrogenases RocG and GudB (Commichau et al., 2008) . We reasoned that degradation of intracellular Glu may allow cells to deplete Glu from the medium and facilitate Asp uptake. Indeed, when RocG was overexpressed from an IPTG inducible P spac(hy) promoter it completely suppressed the lysis phenotype of the aspB null mutant, and the final OD 600 increased from ~0.25 to about 0.35 (Fig. 3C) , possibly due to the ability of cells to more efficiently access Asp from the medium. Similarly, deletion of glutamate synthase GltA, which prevents Glu synthesis, also rescued the aspB lysis phenotype (Fig. 3C ). If these effects of altering Glu metabolism are due to effects on Asp import, then these mutations should be epistatic with gltT. Indeed, in a gltT null background, overexpression of rocG or deletion of gltA could no longer rescue aspB lysis (Fig. 3D ). This is consistent with the hypothesis that consumption of Glu facilitates Asp uptake.
This model makes several predictions about the levels of Glu and Asp in DSM medium (in which aspB cells lyse) and LB medium (in which they do not), and how these levels might be affected by mutations in central metabolism. Using amino acid analysis (Table 1 , SI datasheet), we found that DSM is relatively poor in Asp (0.14 mM free Asp without hydrolysis and 1.68 mM with hydrolysis, as hydrolysis releases free amino acids from oligopeptides) compared to LB (0.55 mM and 3.39 mM respectively), consistent with published work (Sezonov et al., 2007) . These differences in amino acid levels are reflected in the growth yield (final OD 600 ) of the aspB mutant in the two media ( Fig. 2B and D) , and are generally consistent with the dependence of growth yield on Asp supplementation as observed in MM (Fig. S1A ). In addition, DSM contains much more Glu (0.93 mM without and 2.90 mM with hydrolysis) than Asp. Since GltT has a similar affinity for these two amino acids (Zaprasis et al., 2015) , it is likely that Glu competitively inhibits Asp uptake under conditions of our experiments.
This model is further supported by analysis of residual free amino acids after 24 h of growth of the WT, aspB, aspB gltA and aspB P spac(hy) -rocG mutants in DSM. WT The amino acid composition is measured in unhydrolyzed media. This method measures free amino acids in the medium, which includes amino acids sensitive to acid hydrolysis, but does not measure amino acids in oligo-and polypeptides. One measurement was performed for each medium. The measurement was performed by Metabolomics Center, Roy J. Carver Biotechnology Center, University of Illinois at Urbana-Champaign using a GC/MS-based method.
b
The acid hydrolysis was performed by addition of concentrated HCl into media to a final concentration of 6 M in sealed glass tubes. The mixture was placed in a sand bath at 110°C for 24 h for hydrolysis. The mixture was then neutralized to pH 7 by addition of NaOH. Two samples were measured for each medium and the average is shown. The measurement was performed by Metabolomics Center, Roy J. Carver Biotechnology Center, University of Illinois at Urbana-Champaign using GC/MS based method. c Asparagine and glutamine can be hydrolyzed to aspartate and glutamate respectively. The presence of the amine form is likely due to incomplete hydrolysis. d Methionine, serine, threonine, tryptophan and tyrosine are known to be unstable under acid hydrolysis and the data acquired may be lower than the true value to different degrees according to the stability of each amino acid. e Cystine is not reported due to incomplete data acquired from the measurement. cells, which grew to high density (Fig. 3C) , deplete both free Asp (0.05 mM remaining) and Glu (0.1 mM remaining) (Fig. 3E ). In contrast, the aspB mutant failed to grow to high density ( Fig. 3C ) and there was considerable Asp (0.16 mM) and high Glu (1.4 mM) in the spent medium (Fig. 3E) . In aspB mutant cells overexpressing RocG, Glu in the medium was reduced to 0.21 mM and Asp to 0.04 mM, similar to WT (Fig. 3E) . Deletion of gltA also reduced residual Glu in a similar but less dramatic manner, and correspondingly increased the ability of cells to utilize Asp (Fig. 3E) . The additional Asp rendered accessible by lowering Glu is not large (estimated at ~0.1 mM). This is consistent with the small increase in final OD 600 when rocG is overexpressed (from OD 600 0.25 to 0.4, Fig. 3C ), possibly because of limited Asp in DSM. Collectively, these results suggest that high exogeneous Glu competitively inhibits Asp uptake by GltT, thereby exacerbating Asp limitation of the aspB mutant in the relatively Asp-poor DSM.
aspB lysis is caused by depletion of mDAP
In addition to being used for protein synthesis, Asp is used for the synthesis of Lys, Thr, Met and Ile, as well as mDAP for peptidoglycan synthesis and dipicolinic acid for endospores (Fig. 1) . We next tested whether supplementation with any of these metabolites could suppress lysis in DSM. Supplementation with DAP (also known as L, L-diaminopimelic acid or 2,6-DAP, a precursor of mDAP) completely suppressed lysis and allowed cells to achieve a final OD 600 of ~0.5 (Fig. 4A ), close to WT in this medium (maximal OD 600 of 0.7-0.8; Fig. 4B ). We hypothesized that DAP supplementation was providing mDAP for PG synthesis (Fig. 1) , and thereby suppressing cell lysis. However, DAP is also a precursor for Lys. In contrast with DAP, cells grown in DSM supplemented with Lys still showed an initial lysis before a gradual recovery (Fig. 4A) . The slow recovery was not specific to Lys as we also observed some recovery when supplemented with Ile or Trp (Fig. 4A) . Although the WT B. subtilis strain 168 used in this work is a tryptophan auxotroph, Trp is unlikely to be limited for cell growth, as DSM contains ~0.06 mM Trp (Table 1) , which is over ten times higher than the required amount (~0.005 mM) for WT to grow to an OD 600 of ~0.6 in minimal medium (Fig. S2A ). In addition, supplementing DSM with up to 10 mM Trp did not significantly increase cell yield (Fig. S2B) . Thus, both Lys and Trp facilitate recovery of the aspB mutant in a dose dependent manner after lysis, but have no effect on lysis itself (Fig. S3) . We speculate that this effect may result from increased nutrition supply to the not yet lysed cells, which facilitates the cannibalization of Asp from lysed cells. Indeed, supplementation with TCA cycle intermediates also facilitates post-lysis recovery, but has no effect in preventing lysis (Fig. S4) . Overall, the much more dramatic restoration of growth and complete prevention of lysis with DAP compared with Lys suggest that growth limitation and lysis results from a lack of mDAP for PG synthesis.
We also noticed a modest effect in suppressing lysis by supplementation with Met (Fig. 4A) . Met can be synthesized from Asp through a pathway starting with the branch point enzyme homoserine dehydrogenase (Hom) (Fig. 1) . Hom converts L-aspartate semi-aldehyde into homoserine, the precursor for synthesis of Met, Thr and Ile, and can be feedback inhibited by Met (GutierrezPreciado et al., 2009) . We hypothesized that the partial rescue effect from Met may result from inhibition of Hom, which would spare L-aspartate semi-aldehyde for the DapA pathway and synthesis of mDAP (Fig. 1) . Because DSM contains all the amino acids produced by the Hom pathway (Table 1 , SI datasheet), we can delete hom under this growth condition (Fig. 4B ) and test whether this allows a redirection of L-aspartate semi-aldehyde into the DAP pathway. Indeed, deletion of hom completely abolished lysis in the aspB hom double mutant (Fig. 4B) . Overexpression of DapA using an IPTG-inducible promoter led to a similar phenotype (Fig. 4B) , likely because it diverts more L-aspartate semi-aldehyde into the DAP pathway. In contrast, overexpression of Asd, the aspartate semi-aldehyde dehydrogenase that produces the common substrate for Hom and DapA, did not have much effect (Fig. 4B) . SpoVFAB synthesizes dipicolinic acid, an abundant component of endospores, and is a major pathway that consumes precursors for mDAP in sporulating cells (Daniel and Errington, 1993) . Since this pathway is not active in vegetative cells, deletion of spoVFA had no effect on the aspB lysis phenotype (Fig4B).
Amino acid and mDAP limitation are physiologically distinct
An aspB mutant grown in DSM supplemented with 1 mM DAP temporarily ceases growth at roughly the same cell density as in the absence of DAP (OD 600 ~0.3), but lysis (as defined by the loss of optical density) was inhibited and slow growth resumed to a final OD 600 of ~0.45 after 20 h (Fig. 5A) . With 10 mM DAP, cells grew to this same final OD 600 after only 8 h (Fig. 5A) . The similar final cell yield suggests that growth yield is ultimately determined by availability of Asp in the medium. Since the aspB mutant cannot grow to the same cell density as WT, even when supplemented with DAP (Fig. 5B) , we infer that the lowered growth rate and cell yield is due to insufficient Asp (or Asp family amino acids) for protein synthesis.
We hypothesize that the growth rate stimulation with 10 mM compared to 1 mM DAP (Fig. 5A ) may be due to the known ability of mDAP to inhibit aspartokinase I (DapG) (Rosner and Paulus, 1971; Graves and Switzer, 1990 ), which will reduce the amount of Asp used to synthesize other Asp family amino acids.
In addition to its role in Asp synthesis, AspB could in principle function as an anaplerotic enzyme by providing α-ketoglutarate to sustain TCA cycle function. To test whether this might be a cause for the reduced cell yield, we tested the effect of supplementation with both DAP and 10 mM of various TCA cycle intermediates. None of the tested intermediates increased yield beyond that seen with DAP alone (Fig. 5B) , consistent with the idea that reduced growth of the aspB mutant under these conditions is due to an insufficiency of Asp to support protein synthesis. Consistent results were observed in MM: an aspB mutant grown in MM supplemented with a limiting amount of Asp (1 mM) did not display an increase in cell yield when DAP was added (Fig. S1D) .
When an aspB mutant is grown in the presence of 10 mM DAP, cells no longer lyse, and are likely growth limited by the requirement of Asp and Asp family amino acids for protein synthesis (Fig. 1) . This limitation can be exacerbated by removal of the major Asp uptake system, GltT. In the presence of DAP the aspB gltT double mutant grew slowly to OD 600 ~0.5 (Fig. 5C ). The similar final OD 600 for the gltT + and gltT strains suggests that the remaining Asp uptake system(s), presumably GltP and YveA (Tolner et al., 1995 , Lorca et al., 2003 , can still import Asp from the medium, albeit at a lower rate. However, these Asp uptake systems are still sensitive to Glu competition, as addition of 10 mM Glu completely abolished aspB gltT growth, even in the presence of DAP (Fig. 5C ). Overall, these data strongly suggest that when DAP is provided, growth and cell yield of the aspB mutant is determined by the availability of Asp for protein synthesis, whereas when mDAP is limited cell lysis results from a deficiency in PG synthesis. In contrast to the lysis observed in DSM, the aspB mutant did not lyse in MM when a low concentration of Asp was supplemented (0.5 mM or 1 mM, Fig. S1A ). One notable difference between these media is that in MM cells are synthesizing most amino acids and are only provided with Trp (0.24 mM) and a limiting amount of Asp, whereas DSM contains all 20 proteinaceous amino acids (Table 1) . Indeed, when additional amino acids were supplemented into MM, either in the form of casamino acids (CAAs) or a mixture of 17 amino acids (17AAs; the 20 essential amino acids omitting Asp, Asn and Glu), the aspB mutant exhibited rapid lysis after reaching its peak OD 600 (Fig. 5D) . We hypothesized that lysis might be correlated with growth rate, with fast-growing cells having more active autolysins and therefore being more vulnerable to a disruption in A. Growth curve of the aspB mutant growing in DSM supplemented with 1 or 10 mM final concentration of DAP. B. Growth curve of WT and the aspB mutant in DSM supplemented with 10 mM final concentration of DAP, and with or without TCA cycle intermediates (10 mM final concentration). C. Growth curve of mutants in DSM supplemented with 10 mM final concentration of DAP, or 10 mM each of DAP and Glu. D. Growth curve of the aspB mutant in DSM, or MM supplemented with 0.5 mM Asp, 0.5% (w/v) casamino acids, or 0.5 mM Asp and a mixture of 17 amino acids each at concentration of 0.1 mg ml -1 . E. Growth rate of aspB mutant in different media. The growth rate is calculated as log 2 (OD 600-T2 /OD 600-T1 )/(T 2 -T 1 ), in which T 1 and T 2 are two time points in the exponential phase of cell growth. When OD 600 < 0.3, one doubling is approximated as a two-fold increase in OD 600 value. The data is represented as the mean plus or minus one standard error of the mean, and statistically significant different samples (Student's t test, two-tailed P < 0.05) are labelled with different letters. All growth curves were measured at least 3 times and yielded similar results. A representative measurement is shown. [Colour figure can be viewed at wileyonlinelibrary.com] PG synthesis (Tuomanen et al., 1986; Mah and O'Toole, 2001 ). Indeed, under growth conditions that caused lysis of the aspB mutant (DSM, or in MM supplemented with 0.5% CAA or 17AAs) the aspB mutant grew at a rate similar to, or even faster than, that of WT in DSM until Asp was depleted (Fig. 5E ). In comparison, when the aspB mutant was grown in MM with limiting Asp and ammonium as nitrogen source, cells grew slower and did not lyse after Asp depletion. Overall, our results suggest a correlation between growth rate and lysis, with rapid growth contributing to lysis upon mDAP depletion in the cell.
DAP can be imported into B. subtilis by cystine uptake systems TcyABC and TcyP
Previous studies suggest that in E. coli and Salmonella Typhimurium, DAP can be imported by cystine uptake systems, likely due to their structural similarity (Leive and Davis, 1965; Stephen and Nicholas, 1986) (Fig. 6A ). There are two cystine uptake systems in E. coli (Berger and Heppel, 1972) , with TcyJLN able to uptake DAP and TcyP more specific for cystine (Chonoles Imlay et al., 2015) . Uptake of DAP in Bacillus megaterium was resistant to the presence of cystine, suggesting the uptake is not through cystine import pathways (Gally et al., 1991) . However, in the same study Bacillus subtilis 168 exhibited no detectable DAP uptake with or without cystine (Gally et al., 1991) , in contrast to our observation that DAP can suppress the lysis of the aspB mutant.
To investigate if DAP is imported into the cells using cystine uptake systems in B. subtilis, we used the lysis phenotype of the aspB mutant as a readout and tested whether cystine can abolish the rescue of lysis by DAP. With supplementation with 600 μM cystine, 1 mM DAP could no longer prevent the aspB lysis (Fig. 6B) , suggesting that B. subtilis can indeed import DAP and this uptake is likely through cystine uptake pathways. However, the import is likely to be slow and unable to replace endogenous DAP synthesis, as supplementation with 10 mM DAP cannot bypass the essentiality of genes (such as dapB and dapL) upstream of DAP synthesis in the mDAP/ lysine pathway, as tested using CRISPRi based gene knockdown strains , either in LB and DSM (data not shown), or in minimal medium (no cystine to compete with DAP import) supplemented with 3.4 mM Lys (Fig. S5) .
In B. subtilis, there are three cystine uptake systems: TcyABC, TcyJKLMN and TcyP (Burguiere et al., 2004) . TcyABC and TcyJKLMN are ATP binding cassette (ABC) transporters and TcyP is a proton-cystine symporter. To determine which of these three cystine uptake systems are involved in DAP import, we tested mutant strains lacking one, two, or all three systems for the ability of DAP to prevent lysis of the aspB mutant (Fig. 6C) . The results A. Chemical structure of 2,6-DAP and cystine. B. Growth curve of the aspB mutant growing in DSM with or without supplementation with DAP (1 mM final concentration), Cys (600 μM cystine), and DAP + Cys (1 mM DAP and 600 μM cystine). C. Growth curves of different strains in DSM supplemented with 10 mM DAP. All growth curves were measured at least 3 times and yielded similar results. A representative measurement is shown. [Colour figure can be viewed at wileyonlinelibrary .com] suggest that TcyABC and TcyP are the two major DAP uptake systems, with TcyJKLMN playing little if any role. The limited role for TcyJKLMN was surprising since import of L-[
14 C]-cystine by this system is known to be partially inhibited by mDAP (Burguiere et al., 2004) . Regardless, our results suggest that TcyJKLMN does not import sufficient DAP to suppress lysis and support growth under these conditions.
Depletion of mDAP causes cell wall stress and cell morphology defects
Since mDAP is an essential substrate for PG synthesis, mDAP limitation is predicted to impair PG synthesis ultimately leading to cell lysis. Indeed, microscopic images revealed many bulged cells and cell debris when the aspB mutant was grown in liquid DSM, while such deformed cells were rare in the 168 WT (Fig. 7A , red arrows). When supplemented with DAP, the lysis phenotype was suppressed (Fig. 7B) , and bulged cells were much less frequent (Fig. 7E) . Divalent cations such as Mg 2+ are known to suppress PG defects, in part through altering the acetylation level of mDAP in peptidoglycan (Dajkovic et al., 2017) and possibly by other mechanisms including stabilization of negatively charged cell wall through cation-anion interactions. Consistent with the idea that lysis of an aspB null mutant is due to lack of mDAP and weakened PG, addition of 10 mM MgSO 4 suppressed the lysis phenotype of aspB ( Fig. 7B and E) . The alternative sigma factor σ M is known to be upregulated when PG synthesis is inhibited (Helmann, 2016) . Using a P M -lux luciferase reporter containing the σ M dependent autoregulatory promoter of the sigM gene, we found that σ M activity was strongly induced after 3 h of growth in DSM medium, around the same time that growth of the aspB mutant ceased (Fig. 7C, dotted line) . However, within the first hour after growth ceased and cells began to lyse, the σ M activity increased another 2-to 3-fold, as measured by luciferase activity (Fig. 7C, dashed line) . It is worth noting that because the luciferase enzyme we used in this work has an estimated half-life of only 4.2 min (Radeck et al., 2013) did not (Fig. 7D) . We also compared these two mechanisms of suppressing lysis by monitoring cell morphology after 24 h of growth in supplemented DSM. In WT cultures, phase-bright endospores were readily visible after 24 h of growth in DSM, while almost no endospores were present in the aspB mutant. Addition of DAP enabled a smaller population to form phase-bright endospores while addition of Mg 2+ apparently did not. Using Oufti software (Paintdakhi et al., 2016) , we scored more than 600 cells (exclusive of spores) for each strain and growth condition, and measured cell length and width and calculated the width to length ratio ( Fig. 7E and F) . Insufficient peptidoglycan synthesis in the aspB mutant significantly changed cell shape: the aspB mutant was about 11% shorter and 13% wider than WT cells, causing a 27% increase in the width to length ratio (Fig. 7F) . Addition of DAP or Mg 2+ did not strongly affect the width/length ratio of WT cells. However, supplementation with DAP partially reversed the shape effects in the aspB mutant and reduced the change in aspect ratio from a 27% to a 9% increase relative to WT. In contrast, addition of Mg 2+ did not restore cells to a more WT shape (Fig. 7F ). In fact, the aspB mutant supplemented with Mg 2+ displayed a further increase of the width to length ratio relative to WT (Fig. 7F ). These data suggest that although addition of DAP and Mg 2+ suppress cell lysis, the intrinsic differences between the two mechanisms result in different cell morphologies.
Limitation of mDAP sensitizes cells to cell wall antibiotics
Since the aspB mutant is limited for mDAP availability, we tested the effect on sensitivity against several antibiotics targeting PG synthesis. For this analysis, we used Mueller-Hinton (MH) medium in which aspB mutant has less of a growth defect than in DSM: single colonies grow with normal morphology on MH plates, with comparatively mild lysis apparent in the colony centers and the inoculation loading zone (Fig. S6) . Using MH medium, we found that an aspB mutant was no more sensitive than WT to fosfomycin or D-cycloserine (Fig. 8A) , two antibiotics targeting early steps of PG synthesis (Fig.  1) . However, the aspB mutant was significantly more sensitive to antibiotics targeting PG synthesis steps downstream of lipid II, including vancomycin and the beta-lactam antibiotic cefuroxime (Fig. 8A) . Addition of 10 mM Asp completely rescued the sensitivity to vancomycin and partially to cefuroxime ( Fig. 8B and C) , consistent with the sensitivity being caused by a restricted availability of mDAP. Addition of DAP did not rescue sensitivity to vancomycin or cefuroxime (data not shown), possibly due to slow import through the cystine uptake systems. Interestingly, while addition of α-ketoglutarate together with Asp did not have any effect on cefuroxime resistance, it reduced sensitivity to vancomycin in both WT and the aspB mutant background. The mechanism of this altered sensitivity is not yet clear.
Even when grown in the Asp-rich LB medium, the aspB mutant exhibited increased MOE S (Fig. 2B) and, consistently, our original ypmB::mls mutant (polar on the downstream aspB) can become further resistant to MOE when aspB is overexpressed ectopically from an IPTG inducible promoter. As a mimic for the substrate of class A PBPs (aPBPs), MOE is most potent when its aPBP targets are not bound to their true substrate lipid II. The reduced expression of aspB in the ypmB::mls mutant likely leads to partial mDAP depletion and reduced lipid II production. Experiments using a non-polar ypmB mutant revealed strong MOE resistance, similar to a ypmB::mls complemented with an ectopic copy of aspB (data not shown). Overall, the sensitivity of aspB towards vancomycin, cefuroxime and MOE demonstrates that limitation of Asp (and consequently mDAP) sensitizes cells to antibiotics targeting PG synthesis, likely due to a reduced pool of lipid II.
Discussion
It is increasingly appreciated that sensitivity to antibiotics is dependent on the metabolic state of the cell. Changes in carbon source, or from aerobic to anaerobic metabolism, can have dramatic effects on antibiotic susceptibility (Yang et al., 2017; Su et al., 2018) . It may be possible to exploit such effects by combining antibiotics that inhibit essential cellular processes with compounds that alter metabolism to increase susceptibility. Development of new antibiotics also relies on understanding cell metabolism: for example, inhibitors of pathways presumed to be essential, such as fatty acid synthesis, may in fact be ineffective if the targeted organism does not require this pathway in the host (Brinster et al., 2009; Balemans et al., 2010) . To complicate matters further, cell populations are heterogeneous and variations in levels of metabolites or specific proteins may determine survival after antibiotic challenge, and can partially explain the phenomenon of highly resistant persister cells (Lee and Collins, 2011; Fisher et al., 2017; Shan et al., 2017) .
In this work, we show that an aspB null mutation growing in rich medium with limited Asp ceases growth and lyses due to depletion of mDAP, an essential intermediate for PG synthesis. Lysis can be prevented by chemical complementation (DAP supplementation), and this property enabled us to assign two cystine uptake systems (TcyABC and TcyP) as the major DAP importers (Fig. 6  and S5 ). Lysis could also be suppressed by addition of Asp or optimized utilization of available Asp or a variety of genetic manipulations that increased the flux of limited Asp into the DAP pathway. For example, increased consumption of Glu can alleviate competitive inhibition of Asp import (largely through GltT) (Fig. 3) , and provision of Met can spare the branch point intermediate L-aspartate semialdehyde for entry into the DAP pathway (Fig. 4) . Interestingly, a recent study in Salmonella Typhimurium shows that a Met auxotroph (ΔmetB) also affects PG synthesis, and leads to a disproportionate increase relative to WT of UDP-NAM-L-Ala-D-Glu (1000-fold) compared to UDP-NAM-L-Ala-D-Glu-mDAP (5-fold) (Husna et al., 2018) . One possibility is that the metB mutation increases the amount of L-aspartate semi-aldehyde shunted into the Hom pathway for Met synthesis, thereby contributing to a depletion of mDAP and accumulation of the co-substrate for UDP-NAM-L-Ala-D-Glu-mDAP synthesis.
Because an aspB null mutant is unable to de novo synthesize Asp, cells rely on import from the medium to support protein and peptidoglycan synthesis. By measuring amino acid content in DSM and LB medium, we propose that the growth defect of the aspB null mutant is due to Asp limitation exacerbated by competition with Glu for Asp uptake. Our results suggest that GltT is the major Glu/Asp importer, and are in agreement with prior work (Zaprasis et al., 2015) , even though our conditions are drastically different (our experiments are done in DSM, a complex medium containing all essential amino acids, whereas Zaprasis et al. used a glucose ammonium based minimal medium supplemented with 20 μM of Glu or Asp). Growth of the aspB mutant can be strongly inhibited by Glu, even in the presence of DAP, suggesting that all major Asp importers are sensitive to Glu-inhibition. Interestingly, Asp uptake is crucial for host colonization of Mycobacterium tuberculosis (Gouzy et al., 2013a (Gouzy et al., ,2013b , highlighting the importance of understanding Asp uptake systems and their role in bacterial physiology.
A major finding of this work is that the growth defect of the aspB mutant on DSM can be separated into two parts. In the presence of added DAP, growth limitation results primarily from amino acid limitation for protein synthesis. In contrast, when no DAP is added the initial response to Asp limitation is cell wall stress, resulting from the lack of mDAP, inducing the σ M regulon and predisposing cells to lysis. A reduced capacity for mDAP synthesis in the aspB null mutant contributes to an aberrant cell morphology (Fig. 7) and sensitivity to antibiotics targeting late steps in PG synthesis (Fig. 8) , likely caused by a limited pool of lipid II. These results are analogous to the cross-talk recently noted in Caulobacter crescentus in which mutations that lead to α-ketoglutarate accumulation can inhibit mDAP synthesis, leading to antibiotic sensitivity (Irnov et al., 2017) .
In conclusion, in the absence of exogenous DAP, PG synthesis is the first critical process that fails as Asp is depleted (Fig. 7C) . The resultant cell lysis may be dependent on growth rate: when growing slowly in MM, the aspB mutant does not lyse after depletion of Asp and mDAP, while addition of free amino acids increases growth rate and lysis. Interestingly, a similar observation was made over 35 years ago when it was noted that the depletion of mDAP in an auxotrophic strain of E. coli leads to more rapid lysis in fast-growing than slow-growing cells (Leduc et al., 1982) . One possible explanation is that both PG synthesizing and degrading enzymes are more active in fast growing cells than slow-growing cells, and thus the imbalance is more severe in fast-growing cells when PG synthesis is limited by mDAP depletion. Overall, this work highlights the important connection between central metabolism and cell wall synthesis and reveals how alterations in central metabolism that limit peptidoglycan sidechain biosynthesis may increase sensitivity to peptidoglycan synthesis inhibitors.
Experimental procedures
Strains, primers, media and growth condition
All strains used in this work are listed in Table 2 , and all DNA primers are listed in Table S1 . Bacteria were routinely grown in liquid lysogeny broth (LB), Difco Sporulation Medium (DSM) or minimal medium (MM) with vigorous shaking, or on plates (1.5% agar; Difco) at 37°C unless otherwise stated. LB medium contains 10 g tryptone, 5 g yeast extract, and 5 g NaCl per liter. DSM (per 500 ml) includes 5 ml 10% KCl, 5 ml 1.2% MgSO 4 *7H 2 O, 4 g Bacto nutrient broth powder, 0.25 ml 1 M NaOH and water to bring the volume to 500 ml. The medium is autoclaved at 121°C for 20 min. After autoclaving, the following filter sterilized ingredients were added: 0.5 ml 1 M Ca(NO 3 ) 2 , 0.05 ml 0. MnCl 2 , 1 μM FeSO 4 and 0.5 mM MgSO 4 . The mixture of 17 amino acids includes alanine, arginine, cysteine, glutamine, glycine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine and valine. Final concentrations for each amino acid used in the growth measurement is 0.1 mg ml -1
. For growth curve measurements, 1 μl log phase culture (OD 600 ~0.4) was inoculated into 200 μl of liquid medium per well in a Bioscreen 100-well plate, the plate was shaken vigorously and OD 600 was measured every 15 min using an automated BioScreen growth analyzer. Plasmids were constructed using standard methods (Luo et al., 2010) , and amplified in E. coli DH5α before transforming into B. subtilis. For selection of transformants, 100 μg ml -1 ampicillin was used for E. coli. Antibiotics used for selection of B. subtilis transformants include: kanamycin 15 μg ml -1
, spectinomycin 100 μg ml -1
, macrolide-lincosamide-streptogramin B (MLS, contains 1 μg ml -1 erythromycin and 25 μg ml -1 lincomycin), and chloramphenicol 10 μg ml -1 . 
Genetic techniques
LFH PCR, chromosomal and plasmid DNA transformation was performed as previously stated (Zhao et al., 2016) . The kanamycin resistance and MLS resistance cassettes were PCR amplified from plasmids pDG780 and pDG646 respectively (Guerout-Fleury et al., 1995) . The pPL82 plasmid-based P spac(hy) overexpression constructs were linearized and integrated into the amyE locus (Quisel et al., 2001) . Markerless in-frame deletion mutants (indicated by ∆ in Table 2 ) were constructed from BKE strains as described (Koo et al., 2017) . Briefly, BKE strains were acquired from the Bacillus Genetics Stock Center, chromosomal DNA was extracted, and the mutation containing an erm R cassette was transformed into our WT 168 strain. The erm R cassette was subsequently removed by introduction of the Cre recombinase carried on plasmid pDR244, which was later cured by growing at the non-permissive temperature of 42°C. Gene deletions were confirmed by PCR screening using flanking primers. Unless otherwise described, all PCR products were generated using B. subtilis 168 strain chromosomal DNA as template. DNA fragments used for gene over-expression were sequence verified. Null mutant constructions were verified by PCR. The mutant missing the entire tcyJKLMN operon was constructed in three steps. Briefly, a fragment containing the region upstream of tcyJ and adjacent erm cassette was amplified from BKE29380 (tcyJ::erm), and another fragment containing the erm cassette and downstream region of tcyN was amplified from BKE29340 (tcyN::erm). These two fragments were joined by overlap PCR using the shared erm cassette and yielded a fragment containing the upstream of tcyJ and the downstream of tcyN, with the entire tcyJKLMN operon replaced by an erm cassette. The fragment was used to transform WT strain and the erm cassette was later removed by the Cre recombinase encoded on plasmid pDR244. Unless otherwise stated, the aspB strain was used as a representative null mutant, and the aspB::kan or aspB::erm allele was used for construction of strains with multiple mutations (Table 2 ). The ∆aspB, aspB::kan and aspB::erm strains were compared in most growth experiments and were phenotypically indistinguishable.
Disk Diffusion Assay
Disk diffusion assays was performed as previously described (Kingston et al., 2014) . Briefly, overnight cultures in LB medium were inoculated into fresh LB medium and grown to exponential phase with OD 600 of 0.4. A 100 μl aliquot of each culture was mixed with 4 ml of 0.75% MH soft agar (kept at 50°C) and directly poured onto a prewarmed 37°C MH plate (containing 15 ml of 1.5% MH agar). After the soft agar solidified, a filter paper disk with diameter of 6.5 mm was placed on top of the soft agar, and an antibiotic to be tested was added to the paper disk. The plate incubated at 37°C for 20 h. The overall diameter of the inhibition zone was measured along two pairs of orthogonal lines, and zones of inhibition are reported as the average diameter of the four measurements for each biological replicate. At least four biological replicates were used for each antibiotic and strain combination. The quantity of antibiotics used per disk is cefuroxime 10 μg, vancomycin 50 μg, D-cycloserine 500 μg, or fosfomycin 500 μg.
Amino Acid Analysis
Amino acid analysis (AAA) was performed by Metabolomics Center, Roy J. Carver Biotechnology Center, University of Illinois at Urbana-Champaign using GC/MS based method. For AAA of spent medium, cells were grown for 24 h, and then removed by centrifugation at 5000 g for 10 min, followed by filtration of the supernatant through a 0.22 μm filter. Concentrations of free amino acids were measured using a quantitative GC/MS-based method. To measure total amino acids in media which contain oligo-and polypeptides, the medium was hydrolyzed (Davidson, 2003) . Briefly, HCl was added to 6 M and samples kept at 110 ˚C in a sand bath for 24 h. Hydrolyzed medium was then centrifuged at 5000 g for 10 min, followed by filtration through a 0.22 μm filter to remove particles formed during the hydrolysis. Hydrolyzed medium containing 6 M HCl was neutralized by NaOH to pH 7.0 before AAA.
Luciferase reporter construction and measurement
The P M -lux luciferase reporter was constructed by inserting the σ M -controlled promoter of sigM (P M ) amplified using primers 6808 and 6809 into the multicloning sites of pBS3Clux (Radeck et al., 2013) . The insert was confirmed by sequencing, the plasmid was linearized and integrated into the B. subtilis sacA locus. For luciferase measurements, 1 μl of exponentially growing cells were inoculated into 99 μl of fresh medium in a 96 well plate, incubated at 37°C with shaking using a SpectraMax i3x plate reader. Because the luciferase has a short half-life (~4 min), OD 600 and luminescence were measured every 12 min. The data were analyzed using SoftMax Pro 7.0 software. P M promoter activity was normalized by dividing the relative light units (RLU) by OD 600 .
Phase contrast microscopy
Cells were grown in liquid medium for the time indicated and loaded on saline (0.90% NaCl, w/v) agarose pads (0.8% final concentration) on a glass slide. Phase contrast images were taken using a Leica DMi8 microscope equipped with a 100x immersion objective and Leica Application Suite X software. Cell length and width were measured using Oufti per the software's instruction (Paintdakhi et al., 2016) .
